JP2013503642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013503642A5 JP2013503642A5 JP2012528058A JP2012528058A JP2013503642A5 JP 2013503642 A5 JP2013503642 A5 JP 2013503642A5 JP 2012528058 A JP2012528058 A JP 2012528058A JP 2012528058 A JP2012528058 A JP 2012528058A JP 2013503642 A5 JP2013503642 A5 JP 2013503642A5
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- antibody
- subject
- cdna
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23963009P | 2009-09-03 | 2009-09-03 | |
| US61/239,630 | 2009-09-03 | ||
| PCT/US2010/047721 WO2011028933A1 (en) | 2009-09-03 | 2010-09-02 | Type 1 interferon diagnostic |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015075518A Division JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013503642A JP2013503642A (ja) | 2013-02-04 |
| JP2013503642A5 true JP2013503642A5 (https=) | 2013-10-17 |
| JP5727484B2 JP5727484B2 (ja) | 2015-06-03 |
Family
ID=43649646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528058A Expired - Fee Related JP5727484B2 (ja) | 2009-09-03 | 2010-09-02 | Ｉ型インターフェロン診断法 |
| JP2015075518A Pending JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015075518A Pending JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20120251546A1 (https=) |
| EP (1) | EP2473636B1 (https=) |
| JP (2) | JP5727484B2 (https=) |
| KR (1) | KR20120101340A (https=) |
| CN (1) | CN102753704A (https=) |
| AU (1) | AU2010289383B2 (https=) |
| BR (1) | BR112012004781A2 (https=) |
| CA (1) | CA2772921A1 (https=) |
| CY (1) | CY1118566T1 (https=) |
| DK (1) | DK2473636T3 (https=) |
| ES (1) | ES2613055T3 (https=) |
| HR (1) | HRP20170091T1 (https=) |
| HU (1) | HUE032917T2 (https=) |
| LT (1) | LT2473636T (https=) |
| ME (1) | ME02599B (https=) |
| MX (1) | MX2012002640A (https=) |
| PL (1) | PL2473636T3 (https=) |
| PT (1) | PT2473636T (https=) |
| RS (1) | RS55641B1 (https=) |
| RU (1) | RU2012112802A (https=) |
| SI (1) | SI2473636T1 (https=) |
| SM (2) | SMT201700063T1 (https=) |
| WO (1) | WO2011028933A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2488632A1 (en) * | 2002-06-11 | 2003-12-18 | Idaho Research Foundation | Type i interferon-inducible proteins to detect viral infection |
| EP2712930A3 (en) * | 2006-12-06 | 2014-04-23 | MedImmune, LLC | Interferon alpha-induced pharmacodynamic markers |
| CA2686861A1 (en) * | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| KR20140048877A (ko) * | 2011-04-26 | 2014-04-24 | 제넨테크, 인크. | 자가면역 질환의 치료를 위한 조성물 및 방법 |
| WO2013101771A2 (en) * | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| KR102320059B1 (ko) | 2012-06-13 | 2021-11-01 | 아스트라제네카 아베 | 항-i형 인터페론 수용체(ifnar) 항체에 대한 고정 투여 계획 |
| JP6531306B2 (ja) * | 2015-02-20 | 2019-06-19 | 一三 西野 | 炎症性筋疾患鑑別マーカー及びそれを用いた炎症性筋疾患と非炎症性筋疾患の鑑別方法 |
| CN105316404B (zh) * | 2015-02-27 | 2017-02-22 | 中南大学湘雅二医院 | 系统性红斑狼疮生物标志物及其诊断试剂盒 |
| AU2017231833B2 (en) | 2016-03-10 | 2024-03-14 | Viela Bio, Inc. | ILT7 binding molecules and methods of using the same |
| CN105567861B (zh) * | 2016-03-16 | 2018-12-14 | 宫蕊 | Ifi27作为冠心病诊断标志物的用途 |
| SG11202108679PA (en) * | 2019-02-15 | 2021-09-29 | Astrazeneca Ab | Type i interferon-mediated disorders |
| EP4494712A3 (en) | 2019-11-11 | 2025-03-26 | Astrazeneca AB | Type i interferon inhibition in systemic lupus erythematosus |
| EP4157873A2 (en) | 2020-05-29 | 2023-04-05 | Astrazeneca AB | Treatment of cardiometabolic disease with inhibitors of type i interferon signalling |
| JP2023544351A (ja) * | 2020-10-02 | 2023-10-23 | セルジーン コーポレーション | 全身性エリテマトーデスを治療する方法及び治療に対する臨床的感受性の予測因子としてのバイオマーカの使用 |
| TW202237647A (zh) | 2020-10-08 | 2022-10-01 | 瑞典商阿斯特捷利康公司 | 狼瘡發作之治療 |
| WO2022106460A2 (en) | 2020-11-18 | 2022-05-27 | Astrazeneca Ab | Steroid sparing |
| CA3216395A1 (en) | 2021-04-23 | 2022-10-27 | Astrazeneca Ab | Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumab |
| CA3216390A1 (en) | 2021-04-23 | 2022-10-27 | Astrazeneca Ab | Treatment of cutaneous lupus erythematous |
| CN120392997A (zh) | 2021-04-23 | 2025-08-01 | 阿斯利康(瑞典)有限公司 | 用于皮下注射的抗ifnar1给药方案 |
| MX2023013015A (es) * | 2021-05-04 | 2023-11-15 | Viela Bio Inc | Metodos de tratamiento de trastornos autoinmunitarios con proteinas de union al transcrito 7 similar a inmunoglobulina (ilt7). |
| IL308128A (en) | 2021-05-12 | 2023-12-01 | Astrazeneca Ab | Inhibitor of type 1 interferon receptor steroid sparing in systemic lupus erythematosus patients |
| KR20240038773A (ko) | 2021-07-27 | 2024-03-25 | 아스트라제네카 아베 | 루푸스의 치료 |
| JP2024536320A (ja) | 2021-10-04 | 2024-10-04 | アストラゼネカ・アクチエボラーグ | ループスの処置 |
| IL319505A (en) | 2022-09-14 | 2025-05-01 | Viatris Asia Pacific Pte Ltd | S1P 1 receptor modulators for use in the treatment of diseases mediated by type 1 interferon |
| CN120344259A (zh) | 2022-10-13 | 2025-07-18 | 阿斯利康(瑞典)有限公司 | 狼疮的治疗 |
| AU2024277546A1 (en) | 2023-05-19 | 2026-01-15 | Astrazeneca Ab | Treatment of lupus |
| WO2025022280A1 (en) | 2023-07-21 | 2025-01-30 | Astrazeneca Ab | Treatment of neurodegenerative diseases |
| GB202315831D0 (en) | 2023-10-16 | 2023-11-29 | Astrazeneca Ab | Treatment of skin disease |
| GB202402824D0 (en) | 2024-02-28 | 2024-04-10 | Astrazeneca Ab | Treatment of chronic kidney disease |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0139676B1 (en) | 1983-02-04 | 1992-11-25 | Cytoclonal Pharmaceutics Inc. | Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
| GB8303165D0 (en) | 1983-02-04 | 1983-03-09 | Secher D S | Monoclonal antibody |
| DE3306060A1 (de) | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
| EP0205404B1 (en) | 1985-06-11 | 1992-07-15 | Ciba-Geigy Ag | Hybrid interferons |
| US7247425B2 (en) * | 1998-01-30 | 2007-07-24 | Evolutionary Genomics, Llc | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| US7749695B2 (en) * | 2003-03-03 | 2010-07-06 | Alexander Abbas | PRO polypeptides for diagnosis of systemic lupus erythematosis |
| CA2458085A1 (en) * | 2003-03-21 | 2004-09-21 | F. Hoffmann-La Roche Ag | Transcriptional activity assay |
| JP2007525458A (ja) | 2003-04-23 | 2007-09-06 | メダレックス インコーポレイテッド | インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体 |
| KR101225299B1 (ko) | 2003-12-10 | 2013-01-24 | 메다렉스, 인코포레이티드 | 인터페론 알파 항체 및 그의 용도 |
| JP2007527247A (ja) * | 2004-03-05 | 2007-09-27 | ロゼッタ インファーマティクス エルエルシー | 臨床的基準および情報提供性遺伝子セットの組合せを使用する乳癌患者の分類 |
| US7662381B2 (en) | 2004-06-21 | 2010-02-16 | Medarex, Inc. | Interferon alpha receptor 1 antibodies and their uses |
| DK2327792T3 (da) * | 2005-08-05 | 2014-01-13 | Genentech Inc | Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme |
| WO2007123765A2 (en) * | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
| EP2052088A2 (en) * | 2006-08-02 | 2009-04-29 | Genizon Biosciences | Genemap of the human genes associated with psoriasis |
| EP2712930A3 (en) * | 2006-12-06 | 2014-04-23 | MedImmune, LLC | Interferon alpha-induced pharmacodynamic markers |
| CA2686861A1 (en) * | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| US20100209914A1 (en) * | 2007-05-25 | 2010-08-19 | Ore Pharmaceuticals , Inc. | Methods, systems, and kits for evaluating multiple sclerosis |
| KR20110005783A (ko) * | 2008-02-08 | 2011-01-19 | 메디뮨 엘엘씨 | 질환 마커 및 그의 용도 |
| US20110117563A1 (en) * | 2008-04-21 | 2011-05-19 | Witold Filipowicz | Antiviral therapy |
| WO2009149319A2 (en) * | 2008-06-05 | 2009-12-10 | Wyeth | Gene expression profiles associated with asthma exacerbation attacks |
-
2010
- 2010-09-02 CA CA2772921A patent/CA2772921A1/en not_active Abandoned
- 2010-09-02 SI SI201031376A patent/SI2473636T1/sl unknown
- 2010-09-02 ES ES10814513.7T patent/ES2613055T3/es active Active
- 2010-09-02 BR BR112012004781A patent/BR112012004781A2/pt not_active IP Right Cessation
- 2010-09-02 SM SM20170063T patent/SMT201700063T1/it unknown
- 2010-09-02 US US13/393,616 patent/US20120251546A1/en not_active Abandoned
- 2010-09-02 WO PCT/US2010/047721 patent/WO2011028933A1/en not_active Ceased
- 2010-09-02 MX MX2012002640A patent/MX2012002640A/es not_active Application Discontinuation
- 2010-09-02 RS RS20170089A patent/RS55641B1/sr unknown
- 2010-09-02 LT LTEP10814513.7T patent/LT2473636T/lt unknown
- 2010-09-02 HU HUE10814513A patent/HUE032917T2/hu unknown
- 2010-09-02 PT PT108145137T patent/PT2473636T/pt unknown
- 2010-09-02 HR HRP20170091TT patent/HRP20170091T1/hr unknown
- 2010-09-02 CN CN2010800447566A patent/CN102753704A/zh active Pending
- 2010-09-02 JP JP2012528058A patent/JP5727484B2/ja not_active Expired - Fee Related
- 2010-09-02 ME MEP-2017-24A patent/ME02599B/me unknown
- 2010-09-02 AU AU2010289383A patent/AU2010289383B2/en not_active Ceased
- 2010-09-02 DK DK10814513.7T patent/DK2473636T3/en active
- 2010-09-02 PL PL10814513T patent/PL2473636T3/pl unknown
- 2010-09-02 RU RU2012112802/10A patent/RU2012112802A/ru not_active Application Discontinuation
- 2010-09-02 KR KR1020127008547A patent/KR20120101340A/ko not_active Withdrawn
- 2010-09-02 EP EP10814513.7A patent/EP2473636B1/en active Active
-
2015
- 2015-03-18 US US14/662,134 patent/US20150191788A1/en not_active Abandoned
- 2015-04-02 JP JP2015075518A patent/JP2015147788A/ja active Pending
- 2015-10-06 US US14/876,549 patent/US20160024205A1/en not_active Abandoned
-
2017
- 2017-01-26 SM SM201700063T patent/SMT201700063B/it unknown
- 2017-01-26 CY CY20171100112T patent/CY1118566T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013503642A5 (https=) | ||
| HRP20170091T1 (hr) | Dijagnostika interferona tip 1 | |
| JP2012518421A5 (https=) | ||
| JP2010529857A5 (https=) | ||
| JP2019196400A5 (https=) | ||
| JP2012531202A5 (https=) | ||
| EP2603605B1 (en) | A method for classifying an inflammatory bowel disease as a crohn's disease or as an ulcerative colitis | |
| JP2010526107A5 (https=) | ||
| JP2014509862A5 (https=) | ||
| JP2011101652A5 (https=) | ||
| JP2020505920A5 (https=) | ||
| JP2010535480A5 (https=) | ||
| JP2009523005A5 (https=) | ||
| JP2012514451A5 (https=) | ||
| JP2013505020A5 (https=) | ||
| MX346956B (es) | Captura directa, amplificación y secuenciación de objetivo adn usando cebadores inmovilizados. | |
| JP2012503985A5 (https=) | ||
| JP2010035552A5 (https=) | ||
| JP2009544314A5 (https=) | ||
| WO2006029184A3 (en) | Genes useful for diagnosing and monitoring inflammation related disorders | |
| JP2015528294A5 (https=) | ||
| JP2006518186A5 (https=) | ||
| JP2017521654A5 (https=) | ||
| JP2005511023A5 (https=) | ||
| JP2019506849A5 (https=) |